SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-55182"
 

Sökning: id:"swepub:oai:DiVA.org:oru-55182" > Prognostic signific...

Prognostic significance of phospho-histone H3 in prostate carcinoma

Nowak, Michael (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany.; Dept Prostate Canc Res, Univ Hosp Bonn, Bonn, Germany.
Svensson, Maria A. (författare)
Region Örebro län,Dept Lab Med, Univ Hosp Örebro, Örebro, Sweden; Dept Urol, Univ Hosp Örebro, Örebro, Sweden; Inst Hlth & Med Sci, Univ Örebro, Örebro, Sweden
Carlsson, Jessica, 1984- (författare)
Region Örebro län,Örebro universitet, Institutionen för hälsovetenskap och medicin,Dept Urol, Örebro, Örebro University Hospital, Örebro, Sweden
visa fler...
Vogel, Wenzel (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany; Dept Prostate Canc Res, Univ Hosp Bonn, Bonn, Germany
Kebschull, Moritz (författare)
Dept Periodontol Operat & Prevent Dent, Univ Bonn, Bonn, Germany
Wernert, Nicolas (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany
Kristiansen, Glen (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany
Andren, Ove, 1963- (författare)
Region Örebro län,Örebro universitet, Institutionen för hälsovetenskap och medicin,Dept Urol, Örebro University Hospital, Örebro, Sweden
Braun, Martin (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany.; Dept Prostate Canc Res, Univ Hosp Bonn, Bonn, Germany
Perner, Sven (författare)
Inst Pathol, Univ Hosp Bonn, Bonn, Germany.; Dept Prostate Canc Res, Univ Hosp Bonn, Bonn, Germany
visa färre...
Region Örebro län Inst Pathol, Univ Hosp Bonn, Bonn, Germany; Dept Prostate Canc Res, Univ Hosp Bonn, Bonn, Germany. (creator_code:org_t)
2013-07-26
2014
Engelska.
Ingår i: World journal of urology. - : Springer-Verlag New York. - 0724-4983 .- 1433-8726. ; 32:3, s. 703-707
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Prostate cancer is the second most common cancer in men and the sixth most common cause of death from cancer in men worldwide. Currently, a sufficient pathological distinction between patients requiring further treatment and those for which active surveillance remains an option is still lacking, which leads to the problem of overtreatment. Cell proliferation is routinely assessed by detecting Ki-67 antigen. While Ki-67 is expressed throughout the interphase of proliferating cells, phosphorylation of the chromatin constituent histone H3 occurs only during the late G2 phase and mitosis thus providing a more strict assessment of the mitotic activity. We undertook this study to test whether expression of the recently introduced proliferation marker phospho-histone H3 (pHH3) in prostate carcinoma tissue sections exhibits prognostic significance in comparison with Ki-67. Protein expression of pHH3 and Ki-67 was assessed on TMA consisting of paraffin-embedded tissue from men that had undergone radical prostatectomy. The analysis included triplicate tissue cores of a total of 339 tumor foci. Immunohistochemical staining of pHH3 and Ki-67 was performed and analyzed using Definiens imaging software. Prostate cancer tissue exhibited a significantly higher frequency of pHH3-positive cells compared to benign prostate tissue. pHH3 expression was significantly correlated with Ki-67 expression. Furthermore, statistical analysis revealed positive correlation between pHH3 expression and PSA levels at diagnosis and in addition negatively correlated with overall survival. In contrast to Ki-67 staining, pHH3 expression did not correlate with Gleason grade. Our data point to a conceivable role of pHH3 as prognostic biomarker in prostate carcinoma.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

Nyckelord

Prostate cancer
Phospho-histone H3
Mitosis
Prognostic marker

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy